---
title: "SENSTEED: Net profit of 219 million yuan in the first half of 2025, a year-on-year increase of 119.34%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254821471.md"
description: "SENSTEED announced that its operating revenue in the first half of 2025 was 1.732 billion yuan, a year-on-year decrease of 17.30%. The net profit was 219 million yuan, a year-on-year increase of 119.34%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into capital stock"
datetime: "2025-08-27T12:52:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254821471.md)
  - [en](https://longbridge.com/en/news/254821471.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254821471.md)
generator: "portal-rs"
---

# SENSTEED: Net profit of 219 million yuan in the first half of 2025, a year-on-year increase of 119.34%

SENSTEED announced that its operating revenue in the first half of 2025 was 1.732 billion yuan, a year-on-year decrease of 17.30%. The net profit was 219 million yuan, a year-on-year increase of 119.34%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital

### Related Stocks

- [000981.CN](https://longbridge.com/en/quote/000981.CN.md)

## Related News & Research

- [China Changbaishan International Holdings announces special general meeting](https://longbridge.com/en/news/296834310.md)
- [REG - Windar Photonics PLC - Result of Placing & Direct Subscription](https://longbridge.com/en/news/296816414.md)
- [Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three and Six Months Ended June 30, 2026 | EMYB Stock News](https://longbridge.com/en/news/296930370.md)
- [AL Sydbank A/S share buyback programme: transactions in week 34](https://longbridge.com/en/news/296759170.md)
- [America Great Health reports interim data from ion-modified peptide adjunctive therapy observational study in solid tumors](https://longbridge.com/en/news/296824338.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**